Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed)
Notice NOT-NS-23-082 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 23, 2023 Category: Research Source Type: funding
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
Funding Opportunity RFA-OD-23-020 from the NIH Guide for Grants and Contracts. The goal of this NOFO is to support doctoral candidates studying high-priority areas of child health for the completion of their doctoral dissertation research project. This NOFO seeks to advance research in child health by stimulating the use of Environmental Influences on Child Health (ECHO) Cohort data by doctoral students in relevant scientific areas. This RFA will provide students working on dissertations the opportunity to access the ECHO data within the NICHD Data and Specimen Hub (DASH) repository. ECHOs DASH dataset integrates deiden...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 22, 2023 Category: Research Source Type: funding
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Funding Opportunity RFA-OD-23-019 from the NIH Guide for Grants and Contracts. This NOFO seeks to advance research and training in high-priority areas of child health by stimulating the use of Environmental Influences on Child Health Outcomes (ECHO) Cohort data by postdoctoral fellows from relevant scientific communities. This RFA will provide opportunities for fellows to study child health outcomes through the analysis of ECHOs large longitudinal data sets within the NICHD Data and Specimen Hub (DASH) repository. ECHOs DASH dataset integrates deidentified longitudinal data from more than 41,000 participants across the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 22, 2023 Category: Research Source Type: funding
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-24-280 from the NIH Guide for Grants and Contracts. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis of complex circuits and provide insights into cellular interactions that underlie brain function. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application. The development of new ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 16, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Neuropathogenesis of CNS Complications Associated with HIV
Notice NOT-MH-23-280 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 15, 2023 Category: Research Source Type: funding
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-207 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2023 Category: Research Source Type: funding
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Funding Opportunity PAR-23-208 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advanceadavnce mechanistic understanding of both biobehavioral and neurobiologfical pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the develo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2023 Category: Research Source Type: funding
Development and Characterization of Experimental models of post-TBI ADRD (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-23-218 from the NIH Guide for Grants and Contracts. Goal is to have experimental models that can accurately reproduce neuropathological signatures and clinically relevant neurodegenerative, biochemical and behavioral sequelae as those seen in human subjects post-TBI AD/ADRDs. Requirement: Interdisciplinary Team science approach / consortium type of applications. Applications will include multiple sites (3-5 sites) developing and/or testing specific models that will then implement a test of reproducibility across the consortium. Requirement: Must have a clinician with expertise in post-TBI ADRD on...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2023 Category: Research Source Type: funding
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-178 from the NIH Guide for Grants and Contracts. This NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25) is a flexible and specialized program designed to foster the development of neuroscience researchers from diverse backgrounds, including from underrepresented groups across career stages. Thus, it encourages applications from applicant organizations that propose innovative mentoring and professional development activities in the mission area(s) of the NINDS and/or NIMH. This Neuroscience Diversity R25 initiative will focus on factors that have been ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 12, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R34 Clinical Trial Not Allowed)
Notice NOT-NS-23-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 8, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Notice of Funding Opportunity for Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
Notice NOT-NS-23-070 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 6, 2023 Category: Research Source Type: funding
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-23-214 from the NIH Guide for Grants and Contracts. "This FOA will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 6, 2023 Category: Research Source Type: funding
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-23-212 from the NIH Guide for Grants and Contracts. This FOA would support establishing deeper mechanistic insight and causal relationships between TDP-43 pathology and phenotypic outcomes, as well as mechanistic interactions between TDP-43 and other co-pathologies, such TMEM106B. Additionally, it would include comparisons (including mechanistic, molecular, structural, cellular, genetic, -omic, anatomical, neuropathological, etc.) between TDP-43 proteinopathies, including LATE, with or without AD-NC, and FTD and/or ALS. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 23, 2023 Category: Research Source Type: funding
Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-23-211 from the NIH Guide for Grants and Contracts. This FOA would support investigations with a minimum of two relevant co-pathologies (e.g., tau, alpha-synuclein, TDP-43, TMEM106B, vascular), with optional risk factors and co-morbidities, to identify cellular and molecular mechanisms of how/why multi-proteinopathy interactions drive worsening neurodegenerative processes and phenotypic outcomes. Studies should examine co-pathology cellular and molecular interactions across brain regions and time in proximate cell population, across various intracellular dynamics and localization, and upstream an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 23, 2023 Category: Research Source Type: funding
Notice of Change to Application and Submission Information for RFA-NS-23-026 "BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)"
Notice NOT-NS-23-086 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 23, 2023 Category: Research Source Type: funding
